Affiliation:
1. Supportive & Palliative Care, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK
Abstract
Purpose of the review
The original World Health Organisation (WHO) cancer pain guidelines were published in 1986 and used globally. Updated guidance was released in 2018. This review compares the ‘old’ with the ‘new’ with a closer look at the relevance of the WHO analgesic ladder in the current climate.
Recent findings
The new guidelines provide a more evidence based, rigorously developed document including recommendations relating to radiotherapeutic management. There is a more detailed focus on safe opioid prescribing, opioid stewardship and the importance of integrating pain management expertise early on in the cancer journey. There remains a lack of evidence for certain therapies despite their widespread use particularly in relation to adjuvants. The pitfalls of the original renowned analgesic ladder are highlighted including a recognition that omitting ‘step 2’ is safe, feasible and cost effective.
Summary
The new guidelines offer more detailed recommendations relevant to clinical practice with a strong focus on safety of opioid prescribing making it relevant in the current climate. The original WHO analgesic ladder is no longer recommended as a strict protocol for cancer pain management.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference37 articles.
1. Is the WHO analgesic ladder still valid? Twenty-four years of experience;Vargus-Schaffer;Can Fam Physician,2010
2. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline;Paice;J Clin Oncol,2022
3. Standards for the management of cancer-related pain across Europe – a position paper from the EFIC task force on cancer pain;Bennett;Eur J Pain,2019
4. Supportive care: an indispensable component of modern oncology;Berman;Clin Oncol (R Coll Radiol),2020
5. The rise of supportive oncology: a revolution in cancer care;Berman;Clin Oncol (R Coll Radiol),2023